Mineralys Therapeutics, Inc.'s total assets for Q1 2026 were $652.86M, a decrease of -1.35% from the previous quarter. MLYS total liabilities were $14.72M for the fiscal quarter, a -2.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.